Paroxysmal Hemicrania: Understanding Severe One-Sided Headaches
Updated: 2 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
Paroxysmal hemicrania is a rare primary headache disorder characterized by sudden, intense, one-sided pain, often occurring multiple times a day. The attacks typically last between 2 and 30 minutes and come with symptoms such as eye redness or a runny nose on the same side as the pain. The exact cause is unknown, but the condition responds very well to a specific medication, indomethacin, so most people can get significant relief [1].
Quick Answer
Paroxysmal hemicrania is a rare primary headache disorder causing sudden, severe pain on one side of the head, typically behind the eye. Attacks last about 2 to 30 minutes, can occur up to 40 times a day and bring tearing or eyelid drooping on the same side. The primary treatment is indomethacin, and response to it helps confirm the diagnosis. [1] [3] [4]
What the research says
Paroxysmal hemicrania is rare. A 2024 systematic review and meta-analysis of 17 clinic-based studies and one population-based study estimated that paroxysmal hemicrania accounts for about 0.3% (95% CI, 0.2% to 0.5%) of adults evaluated for headache in tertiary care, and no cases were found among 1,838 participants in the population-based sample. The most common cranial autonomic symptoms were tearing (77.3%), eye redness (75.0%), and nasal congestion (47.7%). The authors noted an overall high risk of bias across the included studies (Henningsen et al., Headache, 2024).
A dramatic response to indomethacin is the hallmark. A 2023 review in Cephalalgia describes a dramatic response to indomethacin, which is not seen in migraine or the other trigeminal autonomic cephalalgias, as the hallmark of the diagnosis. It also notes that effective alternatives are limited, with other NSAIDs, including newer COX-2 inhibitors, being the most effective (Bahra, Cephalalgia, 2023).
Alternatives exist for people who cannot take indomethacin. A 2021 review in Neurology India reports that pain must respond completely to indomethacin to meet the diagnostic criteria, that attacks last under 20 minutes on average, and that restlessness was added to the criteria in the latest headache classification. COX-2 inhibitors, topiramate, calcium channel blockers, and nerve blocks have improved headache in some people who cannot tolerate indomethacin, and hypothalamic deep brain stimulation has been used in treatment-refractory cases (Paliwal & Uniyal, Neurol India, 2021).
Research summaries are based on article abstracts retrieved from PubMed.
What Is Paroxysmal Hemicrania?
Paroxysmal hemicrania is a distinct and rare type of headache disorder characterized by sudden bursts of severe pain that always affect the same side of the head. As a primary headache disorder, it occurs independently and is not a symptom of another underlying medical condition [1]. The pain is most commonly felt behind the eye but can radiate to other areas on that side of the face.
The frequency of these attacks is a defining feature, with some individuals experiencing headache "waves" a few times a day, while others may face up to 40 attacks in a single 24-hour period. Each episode typically lasts between 2 and 30 minutes [1]. Clinicians categorize the condition into two types: chronic, where attacks occur daily for a year or more, and episodic, where patients have symptom-free breaks lasting more than three months [1].
What are the symptoms and sensory changes of paroxysmal hemicrania?
The pain associated with paroxysmal hemicrania is often described as sharp, stabbing, squeezing, or throbbing [1]. In addition to the intense pain, several physical changes typically occur on the same side of the head as the headache. In a pooled analysis of published studies, tearing and eye redness were the most common of these cranial autonomic symptoms [2].
Symptom Category | Associated Features | Clinical Observations |
Pain Characteristics | Sharp, stabbing, or squeezing | Always one-sided; does not switch. |
Ocular Symptoms | Eye redness, tearing, and eyelid drooping | Eyelid may also appear swollen. |
Nasal & Facial | Runny or stuffy nose; facial sweating | May include flushing of the skin. |
Emotional State | Restlessness or agitation | Occurs along with the headache attack. |

What causes paroxysmal hemicrania, and what can trigger it?
The exact cause of paroxysmal hemicrania is unknown, but research has identified possible links and triggers, such as past head or neck trauma and certain neck movements. Some cases have shown a connection between the onset of these headaches and previous trauma to the head or neck [1].
Specific physical movements can also act as triggers. These include bending the neck, rotating the head, or applying direct pressure to certain areas of the neck. Although the disorder can affect anyone, it is more frequently diagnosed in adults than in children and appears to be more common in females [1].

How is paroxysmal hemicrania diagnosed and treated?
Diagnosing paroxysmal hemicrania requires a thorough clinical evaluation. A healthcare provider will typically begin with a physical exam and a detailed review of the patient's symptoms, focusing on the location, duration, and frequency of the attacks. Blood tests or an imaging test such as an MRI scan can help rule out other conditions with similar symptoms [1].
Clinical Management
The hallmark of paroxysmal hemicrania treatment is its remarkable responsiveness to a specific medication.
Indomethacin: This nonsteroidal anti-inflammatory drug (NSAID) is the primary treatment [1]. It is so effective that a positive response to the medication is used as a diagnostic criterion [3] [4].
Alternative medications: If a patient cannot tolerate indomethacin due to side effects like dizziness or gastrointestinal issues, other options include alternative NSAIDs (aspirin, naproxen), COX-2 inhibitors (celecoxib), or calcium channel blockers (verapamil) [1].
Objective monitoring: Patients are often encouraged to keep a headache journal to track symptoms, triggers, and treatment efficacy, helping providers fine-tune the dosage [1].

What is the outlook and quality of life with paroxysmal hemicrania?
The long-term outlook for individuals with paroxysmal hemicrania is generally good once an effective treatment plan is established. It can take some time to find the right dosage, but most patients find that their symptoms are well-managed with indomethacin. However, because the pain is so severe and frequent, the condition can take a significant toll on mental health and emotional well-being before it is brought under control [1].
Regular follow-up visits are essential, especially for those on long-term NSAID therapy, to monitor for potential side effects and ensure that the treatment remains both safe and effective. Indomethacin, like other NSAIDs, carries a boxed warning for stomach bleeding and for heart attack and stroke risk, so tell your doctor about any ulcer, kidney, or heart history [1].
When should you see a doctor about paroxysmal hemicrania?
If you are experiencing frequent, severe, one-sided headaches, consult a healthcare provider for a professional evaluation. If you already have paroxysmal hemicrania, let your provider know about any new or worsening symptoms or medication side effects. Early diagnosis and targeted treatment can help you regain control of your daily life [1].
Frequently Asked Questions
Is paroxysmal hemicrania the same as a migraine?
No. While both cause severe pain, paroxysmal hemicrania attacks are much shorter (2–30 minutes) and occur much more frequently throughout the day.
Can I take regular ibuprofen for these headaches?
While ibuprofen is an NSAID, paroxysmal hemicrania specifically responds best to indomethacin. Other NSAIDs may be used if indomethacin isn't suitable, so talk to your healthcare provider before choosing a medication.
Does paroxysmal hemicrania ever go away on its own?
Some people have the episodic type, which involves breaks of more than three months, but medical management is usually required to control active attacks.
What is the "indomethacin test"?
Because paroxysmal hemicrania responds so uniquely to indomethacin, doctors often use a patient's positive response to the drug to help confirm the diagnosis.
Are these headaches dangerous?
While the pain is severe, paroxysmal hemicrania is a primary disorder and not usually a sign of a life-threatening condition. However, a doctor must rule out other causes.
Can children get paroxysmal hemicrania?
Paroxysmal hemicrania is rare in children and more common in adults, but it can affect people of any age.
Why does my nose run during a headache?
The same nerve pathways that cause the pain also trigger autonomic responses like a runny nose, tearing, and facial sweating.
What triggers an attack?
Common triggers include rotating the head, bending the neck, or applying pressure to specific points on the neck.
Is there a cure for paroxysmal hemicrania?
There is no permanent cure, but the condition is highly treatable and manageable with the right medication.
How often should I see my doctor?
Regular follow-ups are needed to monitor medication side effects and ensure the dosage remains effective for your needs.
Related Resources
External resource for deeper reading:
Related Reading
Understanding Hemicrania Continua: A Guide to Persistent One-Sided Headaches explains a related constant one-sided headache that also responds to indomethacin.
Cluster Headache: Understanding the Most Painful Headache, and What Treatment Can — and Can't — Do explains the similar one-sided headache with longer attacks.
Trigeminal Neuralgia: What Causes the Facial Pain, and How Is It Treated? covers sudden electric face pain that can mimic short headaches.
Migraine Headaches: What Causes Them and How to Treat Them explains the most common headache disorder and how it is treated.
References
Cleveland Clinic. Paroxysmal Hemicrania. Cleveland Clinic Health Library. Last updated July 3, 2024. https://my.clevelandclinic.org/health/diseases/paroxysmal-hemicrania
Henningsen MJ, Larsen JG, Karlsson WK, et al. Epidemiology and clinical features of paroxysmal hemicrania: A systematic review and meta-analysis. Headache. 2024;64(1):5-15. PMID: 38205903. DOI: 10.1111/head.14658
Bahra A. Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment. Cephalalgia. 2023;43(11):3331024231214239. PMID: 37950675. DOI: 10.1177/03331024231214239
Paliwal VK, Uniyal R. Paroxysmal Hemicrania: An Update. Neurol India. 2021;69(Supplement):S135-S143. PMID: 34003159. DOI: 10.4103/0028-3886.315982
Medical disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have about a medical condition.




Comments